All Articles - Vaticanchannel

Dow Sees Minor Gains Following Jobless Claims; AI Stocks Decline After Earnings Report

The Dow has recorded slight increases in response to the latest jobless claims data, while AI stocks have faced a downturn attributed to disappointing earnings results.

Editorial Staff May 7

Tech AI

Investors Eye Promising IBD 50 Stock Driven by AI and Navy Contracts

An IBD 50 stock is attracting investor attention due to its unique capabilities, particularly in AI data centers and U.S. Navy contracts, suggesting potential for significant growth.

Editorial Staff May 7

Life Medicine

Sanofi Withdraws Teplizumab from FDA Fast-Track Review Amid Internal Disagreements

Sanofi has requested the FDA to withdraw teplizumab from its fast-track review program following internal disagreements regarding the drug's approval.

Editorial Staff May 7

World North America

Howmet Aerospace Surpasses Expectations with Strong Earnings and Revised Guidance

Howmet Aerospace has reported impressive earnings that exceeded market expectations, driven by heightened demand in the aerospace sector, prompting a significant upward revision in its guidance.

Editorial Staff May 7

World Asia Pacific

Tesla's Sales Surge in Korea Highlights the Importance of Affordability for EV Buyers

A significant 330% increase in Tesla sales in Korea during March underscores the critical role of affordability in the electric vehicle market.

Editorial Staff May 7

World North America

Raymond Corp Strengthens Binghamton's Role in Battery Technology

Raymond Corp is reinforcing Binghamton's position as a key player in battery technology with its latest lithium initiatives.

Editorial Staff May 7

Science Research

New Research Aims to Combat Mitochondrial Dysfunction Linked to Aging

A recent study investigates the impact of mitochondrial DNA mutations on aging and various diseases, including neurodegenerative disorders and cancer.

Editorial Staff May 7

Tech AI

FDA Reconsiders Previously Rejected Treatment for Rare Cancer

The FDA is revisiting a rare cancer treatment it had turned down earlier this year, amidst discussions on drug pricing and advancements in biotech.

Editorial Staff May 7

Tech AI

OpenAI Proposes Health Policy Changes Amid Dexcom CGM Developments

OpenAI has released a health policy blueprint while Dexcom updates its continuous glucose monitoring technology, alongside concerns regarding whole body scans.

Editorial Staff May 7

Life Medicine

FDA to Reassess Ebvallo After Unexpected Rejection

Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.

Editorial Staff May 7